Syncona Partners LLP

Syncona Partners is a FTSE250 company that founds, builds and funds healthcare companies with the aim of delivering new treatments in areas of high unmet medical need. Its investment manager builds a portfolio of life science companies across a range of clinical stages, managing them toward value inflection points that can lead to mergers, acquisitions or other liquidity events. The firm says it invests responsibly and aims to manage its business sustainably, supporting portfolio companies as they work toward outcomes that can make a difference to patients and their families. Its portfolio has included companies working on treatments for conditions such as liver disease, retinal disease and other inflammatory and genetic disorders, with several portfolio companies having reported clinical trial results and leadership changes.